http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2780907-T3
Outgoing Links
Predicate | Object |
---|---|
assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_ed266051d5fbde6af8088f11f42dd6b1 |
classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N5-0647 |
classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1833 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-737 |
classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P37-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N5-0789 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-737 |
filingDate | 2014-05-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate | 2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_35cc3b8c33aa935e22b1167723c0b8d3 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ab980798c530603780b9b8603647967 |
publicationDate | 2020-08-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber | ES-2780907-T3 |
titleOfInvention | Dextran sulfate for use in cell mobilization |
abstract | Dextran sulfate having an average molecular weight in a range of 4500 and 7000 Da, or a pharmaceutically acceptable salt thereof, for use in mobilizing progenitor and / or stem cells in the peripheral blood of a subject, said cells being parents and / or mother capable of restoring normal hematopoiesis after chemotherapy or radiation when infused into a subject suffering from a cancer disease selected from the group consisting of acute myeloid leukemia (AML), acute lymphoblastic leukemia (ALL) , chronic myeloid leukemia (CML), myelodysplastic syndromes (MDS), myeloproliferative disorders (PMD), non-Hodgkin lymphoma (NHL), Hodgkin disease (HD), chronic lymphocytic leukemia (CLL), multiple myeloma (MM), chronic myeloid leukemia juvenile, neuroblastoma, ovarian cancer, germ cell tumors, hairy cell leukemia (PCL) and acute promyelocytic leukemia (APL). |
priorityDate | 2013-05-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 132.